We found that compared with cells transfected with control siRNA, silencing SREBP2 in myeloma cells resulted in a decrease in cell viability (Fig. 11E,F), which was, to some extent, rescued by Fer-1 (Fig. 11E,F). Here, SREBF2 is linked to plasma cell myeloma.